| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/04/1999 | CA2296518A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 02/03/1999 | EP0894854A2 A novel splicing variant of the epstein-barr virus-induced g-protein coupled receptor |
| 02/03/1999 | EP0894796A1 Imidazolines substituted with a heterocyclic ring as alpha-2 antagonists |
| 02/03/1999 | EP0894789A1 Substituted indole-2-carboxylic acids as glucosyl transferase inhibitors |
| 02/03/1999 | EP0894133A2 Neuropeptide y receptor y5 and nucleic acid sequence |
| 02/03/1999 | EP0894089A1 Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| 02/03/1999 | EP0894085A1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors |
| 02/03/1999 | EP0894084A1 Cinnamic acid derivatives and their use as integrin antagonists |
| 02/03/1999 | EP0894083A1 Creatine pyruvates and method for their production |
| 02/03/1999 | EP0894000A1 Method for delivering estrogen |
| 02/03/1999 | EP0893995A1 Anticachectic composition |
| 02/03/1999 | EP0793649B1 18,19-dinor-vitamin d compounds |
| 02/03/1999 | EP0729352B1 Interdigitation-fusion liposomes containing arachidonic acid metabolites |
| 02/03/1999 | EP0705275B1 Asp-b28 insulin crystals |
| 02/03/1999 | CN1207047A Cartilage/bone inducing materials for reparation |
| 02/03/1999 | CN1207042A A Pharmaceutical composition for the treatment of autommune diseases |
| 02/03/1999 | CN1206712A Heterocyclic compound, preparation process thereof and medicinal composition containing same |
| 02/03/1999 | CN1206604A Capsule for improving blood circulation and reducing fat |
| 02/02/1999 | US5866702 Purine inhibitors of cyclin dependent kinase 2 |
| 02/02/1999 | US5866611 Phenoxypropylamine inhibitors of squalene synthese, useful in treating diseases in which a lowering of cholesterol is desirable. |
| 02/02/1999 | US5866610 Substituted benzoylguanidines, process for their preparation, their use as a pharmaceutical as inhibitors of the cellular NA+/H+ exchange or as a diagnostic, and pharmaceutical containing them |
| 02/02/1999 | US5866584 Administration of a dopamine agonist, over a limited period at a time of day dependent on the normal circadian rhythm of insulin resistant and insulin sensitive members of a similar species. |
| 02/02/1999 | US5866578 Substituted pyrimidines for control of diabetic complications |
| 02/02/1999 | US5866568 Heterocyclic compounds |
| 02/02/1999 | US5866556 Pyridinylbisphosphonates for use as a therapeutical agent |
| 02/02/1999 | US5866537 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids |
| 02/02/1999 | US5866373 Polynucleotide encoding a human chemotactic protein |
| 02/02/1999 | US5866122 Using prothrombinase |
| 02/02/1999 | CA2053275C Fibroblast growth factor conjugates |
| 01/30/1999 | CA2244435A1 New heterocyclic compounds, their preparation process and the pharmaceutical compounds containing them |
| 01/29/1999 | CA2243882A1 Substituted indole-2-carboxylic acids as glucosyl transferase inhibitors |
| 01/28/1999 | WO1999004000A1 Adipocyte-specific protein homologs |
| 01/28/1999 | WO1999003861A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 01/28/1999 | WO1999003844A1 Pyrazine derivatives, preparation and medicines containing them |
| 01/28/1999 | WO1999003843A1 Polyhydroxyalkylpyrazine derivatives, preparation and medicines containing them |
| 01/28/1999 | WO1999003842A1 Polyhydroxyalkylpyrazine derivatives, preparation and medicines containing them |
| 01/28/1999 | WO1999003841A1 Polyhydroxybutylpyrazines, their preparation and medicines containing them |
| 01/28/1999 | WO1999003839A1 Polyhydroxyalkylpyrazine derivatives, their preparation and medicines containing them |
| 01/28/1999 | WO1999003828A1 Dihomo-seco-cholestanes with two unsaturated bones in the side chain |
| 01/28/1999 | WO1999003478A1 Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor |
| 01/28/1999 | WO1999003477A1 Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide |
| 01/28/1999 | WO1999003476A1 Treatment of diabetes with thiazolidinedione and sulphonylurea |
| 01/28/1999 | WO1999003464A1 Hydroxycitric acid compositions, pharmaceutical and dietary supplements and food products made therefrom, and methods for their use in reducing body weight |
| 01/28/1999 | WO1999003365A1 Nutritional composition containing methionine |
| 01/28/1999 | WO1998049333A3 Eukaryotic gene expression cassette and uses thereof |
| 01/28/1999 | CA2297133A1 Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor |
| 01/28/1999 | CA2296530A1 Adipocyte-specific protein homologs |
| 01/28/1999 | CA2296145A1 Dihomo-seco-cholestanes with two unsaturated bonds in the side chain |
| 01/28/1999 | CA2294830A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 01/27/1999 | EP0893498A2 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor |
| 01/27/1999 | EP0892807A1 Gene family associated with neurosensory defects |
| 01/27/1999 | EP0892791A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors |
| 01/27/1999 | EP0892633A2 Use of inhibitors of the activity of retinoic acid for treating sensitive skin and/or acute damage induced by uv radiation |
| 01/27/1999 | EP0731792B1 Heterocyclic benzenesulfonylimine derivatives as inhibitors of il-1 action |
| 01/27/1999 | CN1206005A Novel inhibitors of bone reabsorption and antagonists of vitronectin receptors |
| 01/27/1999 | CN1041797C Tablets with improved bioavailability of active material clodronic acid |
| 01/27/1999 | CN1041794C Stabilized pharmaceutical composition comprising an. HMG-COA reductase inhibitor compound |
| 01/26/1999 | US5864043 Cardiovascular disorders and angiotensin antagonist |
| 01/26/1999 | US5864036 Substituted imidazole compounds |
| 01/26/1999 | US5863952 Enantiomers of 1-(3,4-dichlorobenzyl)-2-methylaminoindane |
| 01/26/1999 | US5863942 Retinoid conjugate compounds useful for the treatment of aging skin |
| 01/26/1999 | US5863889 ICAM-1/LFA-1 short-chain peptides and method of using same |
| 01/26/1999 | US5863782 Enzymes and genetic sequences |
| 01/26/1999 | US5863766 Isolated, pure polynucleotide encoding a polypeptide for treating vesicle trafficking, immunological, and neoplastic disorders. |
| 01/26/1999 | US5863541 Proteins in cells |
| 01/26/1999 | CA2166692C Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 01/26/1999 | CA2091049C Prophylactic and remedial preparation for diseases attendant on hyperglycemia, and wholesome food |
| 01/26/1999 | CA1340329C Superoxide dismutasee |
| 01/25/1999 | CA2238655A1 Cdna clone my1 that encodes a novel human 7-transmembrane receptor |
| 01/21/1999 | WO1999002696A1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
| 01/21/1999 | WO1999002687A1 Method of increasing the iron content of plant cells |
| 01/21/1999 | WO1999002548A1 A preparation derived from shark cartilage for treatment of diseases related to excessive phf or excessive intracellular calcium |
| 01/21/1999 | WO1999002517A1 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy |
| 01/21/1999 | WO1999002496A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders |
| 01/21/1999 | WO1999002479A1 Method for producing calcium pyruvates |
| 01/21/1999 | WO1999002189A1 Pharmaceutical compositions comprising an aldose reductase inhibitor and an ace inhibitor |
| 01/21/1999 | WO1999002187A2 Decreased fat absorption with an anti-lipase antibody |
| 01/21/1999 | WO1999002170A1 Absorption of minerals by intestinal cells |
| 01/21/1999 | WO1999002149A1 Use of petroselinum acid for treating inflammations |
| 01/21/1999 | WO1999002144A1 Anion regulator for ruminants |
| 01/21/1999 | WO1999002142A2 Novel composition comprising an ssri and a beta-blocker |
| 01/21/1999 | WO1999002041A1 Satiety product |
| 01/21/1999 | CA2298834A1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
| 01/21/1999 | CA2296017A1 Method for producing calcium pyruvates |
| 01/21/1999 | CA2295822A1 Novel composition |
| 01/21/1999 | CA2295735A1 Decreased fat absorption with an anti-lipase antibody |
| 01/21/1999 | CA2295666A1 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy |
| 01/21/1999 | CA2295202A1 Method of increasing the iron content of plant cells |
| 01/21/1999 | CA2294817A1 Use of petroselinum acid for treating inflammations |
| 01/21/1999 | CA2294757A1 Anion regulator for ruminants |
| 01/21/1999 | CA2292480A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders |
| 01/21/1999 | CA2292451A1 Pharmaceutical compositions comprising an aldose reductase inhibitor and an ace inhibitor |
| 01/20/1999 | EP0892049A2 A human pelota homolog |
| 01/20/1999 | EP0891719A1 Nutritional composition containing methionine |
| 01/20/1999 | EP0891424A1 Human cachexia associated protein |
| 01/20/1999 | EP0891378A1 Use of a pharmaceutical composition comprising an appetite-suppressing peptide |
| 01/20/1999 | EP0891332A1 6-phenylpyridyl-2-amine derivatives |
| 01/20/1999 | EP0891326A1 Novel vitamin d analogues |
| 01/20/1999 | EP0891189A1 Medicament for optimising mucosal viscosity and stimulating intestinal function |
| 01/20/1999 | EP0675714B1 COMBINATION OF A CHOLESTEROL BIOSYNTHESIS INHIBITOR AND A $g(b)-LACTAM CHOLESTEROL ABSORPTION INHIBITOR |